Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT07679893 · RECRUITING

Trial details

NCT number: NCT07679893
Sponsor: Mannkind Corporation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis (IPF)

Start date: 2026-06-30
Primary completion: 2028-01-30
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.